Status:
UNKNOWN
Integrated Disease Management of Heart Failure in Primary Care
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study population includes primary care physicians and heart failure (HF) patients attending one of over 100 family physicians in seven family health teams in Southwestern Ontario. Study purpose is...
Detailed Description
The study population will be identified through patients attending one of 100 family physicians from 10 different family health teams (FHTs) or family health organizations (FHOs) in the Southwestern O...
Eligibility Criteria
Inclusion
- New York Heart Association (NYHA) classification of stage II, III or IV
- a clinical diagnosis of HF and a supporting diagnostic echocardiogram
- HF or cardiovascular related hospitalization and/or ED visit in the 24 months prior to recruitment
- Patients with HF with a preserved ejection fraction and HF with a reduced ejection fraction (\<45%) will be included.
Exclusion
- hemodynamic instability
- awaiting cardiac surgery
- expected survival rate of \<1 year due to terminal illness
- lack of English language skills
- reduced cognitive function that affects the ability to complete the questionnaires
- enrolment in other cardiac trials
- formalized HF education (e.g. Telehomecare) in the six months prior to enrolment
- scheduled for cardiac rehabilitation
- severely impaired renal function requiring dialysis.
Key Trial Info
Start Date :
May 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 5 2024
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT04066907
Start Date
May 25 2021
End Date
August 5 2024
Last Update
March 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Science Center, Victoria Hospital
London, Ontario, Canada, N6A 5W9